Phase II trial of radiation therapy/temozolomide/bevacizumab followed by bevacizumab/everolimus in the first- line treatment of glioblastoma multiforme (GBM)

被引：0
|
作者：
Shih, K. C.
Spigel, D. R.
Burris, H. A., III
Brown, R. H.
Shepard, G. C.
Hainsworth, J. D.
机构：
[1] Tennessee Oncol PLLC, Nashville, TN USA
[2] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[3] Sarasota Mem Hosp, Florida Canc Specialists, Sarasota, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2075
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A PHASE II STUDY OF THE EFFICACY OF HYPOFRACTIONATED RADIATION THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE FOLLOWED BY MAINTENANCE TEMOZOLOMIDE AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMAS
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Sachdev, Sean
    Kalapurakal, John A.
    Gondi, Vinai
    Grimm, Sean
    Nicholas, Martin
    Lukas, Rimas V.
    Chmura, Steven J.
    Mehta, Minesh P.
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2017, 19 : 19 - 20
  • [42] TREATMENT OF CHILDREN WITH GLIOBLASTOMA MULTIFORME USING RADIATION, TEMOZOLOMIDE AND BEVACIZUMAB AS ADJUNCTS TO SURGICAL RESECTION
    Spiller, Susan
    Reddy, Alyssa
    Friedman, Gregory
    Fiveash, John
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 965 - 966
  • [43] FIRST-LINE THERAPY WITH BEVACIZUMAB AND IRINOTECAN VERSUS BEVACIZUMAB AND TEMOZOLOMIDE AND DELAYED CONCOMITANT RADIOTHERAPY IN NEWLY DIAGNOSED PRIMARY GLIOBLASTOMA MULTIFORME: EARLY RESULTS FROM A RANDOMIZED PHASE II STUDY
    Hofland, Kenneth F.
    Poulsen, Hans Skovgaard
    Sorensen, Morten P.
    Ask, Anders
    Bertelsen, Anne K.
    Spahn-Horn, Silke
    Hansen, Steinbjorn
    Schulz, Henrik P.
    Lassen, Ulrik
    NEURO-ONCOLOGY, 2009, 11 (05) : 620 - 620
  • [44] Phase II trial for patients with newly diagnosed glioblastoma (GBM) treated with carmustine wafers followed by concurrent radiation therapy (RT), temozolomide (TMZ), and bevacizumab (BV), then followed by TMZ and BV post-RT.
    Ranjan, Tulika
    Peters, Katherine B.
    Vlahovic, Gordana
    Alderson, Lloyd M.
    Herndon, James Emmett
    McSherry, Frances
    Threatt, Stevie
    Sampson, John Howard
    Friedman, Allan H.
    Bigner, Darell D.
    Friedman, Henry S.
    Vredenburgh, James J.
    Desjardins, Annick
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] A phase II trial (N0177) of erlotinib and temozolomide (TMZ) combined with radiation therapy (RT) in glioblastoma multiforme (GBM)
    Brown, P. D.
    Krishnan, S.
    Sarkaria, J.
    Wu, W.
    Mischel, P.
    Yong, W. H.
    Arusell, R.
    Jenkins, R. B.
    Buckner, J. C.
    Giannini, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] BEVACIZUMAB GIVEN WITH TEMOZOLOMIDE AND RADIATION THERAPY (RT) IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) REDUCES THE CHANCE OF EARLY RADIOLOGIC PROGRESSION
    Alderson, Lloyd M.
    Desjardins, Annick
    Ranjan, Tulika
    Peters, Katherine B.
    Friedman, Henry S.
    Vredenburgh, James J.
    NEURO-ONCOLOGY, 2012, 14 : 81 - 81
  • [47] Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma.
    Molaie, Donna
    Lai, Albert
    Ellingson, Benjamin M.
    Thien Nguyen
    Bahng, Hye Hyun
    Filka, Emese
    Green, Stacey
    Pope, Whitney B.
    Leng, Mei
    Yong, William H.
    Green, Richard M.
    Polikoff, Jonathan
    Spier, Liz
    Iwamoto, Fabio Massaiti
    Lassman, Andrew B.
    Cloughesy, Timothy Francis
    Nghiemphu, Phioanh Leia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Phase II Study of Bevacizumab in Combination With Temozolomide as Treatment of Patients With Recurrent Glioblastoma Multiforme: Preliminary Analysis of Toxicity
    Sepulveda, J.
    Belda, C.
    Balana, C.
    Perez Segura, P.
    Reynes, G.
    Gil, M.
    Gallego, O.
    Berrocal, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S589 - S589
  • [49] Bevacizumab in combination with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma multiforme: Preliminary results of a phase II study
    Nicholas, M. K.
    Lucas, R. V.
    Arzbaecher, J.
    Paleologos, N.
    Krouwer, H.
    Malkin, M.
    Omar, A.
    Vick, N. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
    O. L. Chinot
    T. de La Motte Rouge
    N. Moore
    A. Zeaiter
    A. Das
    H. Phillips
    Z. Modrusan
    T. Cloughesy
    Advances in Therapy, 2011, 28 : 334 - 340
12345